Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
Objectives Treatment options for preventing vaso-occlusive crises (VOC) among patients with sickle cell disease (SCD) are limited, especially if hydroxyurea treatment has failed or is contraindicated. A systematic literature review (SLR) and network meta-analysis (NMA) were conducted to evaluate the...
Saved in:
Main Authors: | George Joseph, Howard Thom, Jeroen Jansen, Hung-Yuan Cheng, Jason Shafrin, Lauren Zhao, Subhajit Gupta, Nirmish Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e034147.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study
by: Nirmish Shah, et al.
Published: (2020-06-01) -
Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
by: Nirmish Shah, et al.
Published: (2019-05-01) -
Morphine for the Treatment of Pain in Sickle Cell Disease
by: Mihir Gupta, et al.
Published: (2015-01-01) -
Marked Direct Hyperbilirubinemia due to Ceftriaxone in an Adult with Sickle Cell Disease
by: Daniyeh Khurram, et al.
Published: (2015-01-01) -
Thyroid function abnormalities in individuals with sickle cell disease: a meta-analysis
by: Sagad O. O. Mohamed, et al.
Published: (2025-02-01)